SPBC16C6.04 Antibody

What is SPBC16C6.04 and why is it significant in S. pombe research?

SPBC16C6.04 is a systematic gene identifier in Schizosaccharomyces pombe (fission yeast) that likely encodes a protein involved in cell wall dynamics. Based on homology studies, it may share functional similarities with the Sup11p protein, which shows significant homology to Saccharomyces cerevisiae Kre9 and is involved in β-1,6-glucan synthesis . The significance of studying this protein lies in understanding fundamental cell wall formation processes in yeast, as β-1,6-glucan forms approximately 28% of the fission yeast cell wall and is crucial for maintaining cell wall integrity and morphology .

What types of antibodies are most commonly used for S. pombe cell wall protein detection?

For S. pombe cell wall protein detection, monoclonal antibodies are frequently preferred due to their high specificity and reproducibility. Monoclonal antibodies like those generated from mouse hybridomas (as seen with other protein targets) provide consistent epitope recognition . For research involving SPBC16C6.04 or similar cell wall proteins, antibodies can be produced using recombinant protein expression systems, where the target protein is expressed, purified (often using affinity chromatography methods), and used for immunization . The resulting antibodies can then be purified using Protein A affinity chromatography, similar to the process described for other monoclonal antibodies .

How do I validate an antibody for SPBC16C6.04 recognition in Western blot experiments?

Antibody validation for SPBC16C6.04 recognition should follow a multi-step protocol:

• Positive and negative controls: Use wild-type S. pombe extracts alongside a genetic knockout or knockdown strain (if viable) or extracts from cells where the protein is overexpressed .

• Epitope tagging validation: Compare antibody recognition with detection using tag-specific antibodies (e.g., HA-tag) on samples where SPBC16C6.04 has been epitope-tagged .

• Specific band identification: Verify expected molecular weight, considering potential post-translational modifications, particularly glycosylation which is common in cell wall proteins .

• Deglycosylation tests: Treat samples with endoglycosidase H to remove N-glycans and assess resulting mobility shifts on SDS-PAGE .

• Proteinase K protection assay: Perform this test to determine protein topology, especially for transmembrane or GPI-anchored proteins .

What are the optimal sample preparation methods for S. pombe cell wall proteins?

Optimal preparation of S. pombe samples for cell wall protein analysis requires specific methodological considerations:

• Spheroplasting: For accessing cell wall-embedded proteins, spheroplast S. pombe cells using enzymatic treatment to partially digest the cell wall . This is particularly important for accessing proteins like SPBC16C6.04 that may be embedded within the glucan matrix.

• Biotinylation approach: For cell surface proteins, biotinylation allows specific labeling and subsequent purification. This approach has been successfully used for yeast cell wall proteins and helps distinguish between cell wall-associated and intracellular proteins .

• Fractionation methods: To separate cell wall, membrane, and soluble fractions, use differential centrifugation following cell lysis.

• Buffer selection: Use non-denaturing buffers containing protease inhibitors for initial extraction, followed by more stringent conditions (detergents or chaotropic agents) to solubilize tightly wall-bound proteins.

• Glycoprotein enrichment: For glycosylated proteins, which are common in the cell wall, use lectin affinity chromatography to enrich for these targets prior to immunoprecipitation .

How do post-translational modifications affect SPBC16C6.04 antibody recognition and what techniques can overcome these challenges?

Post-translational modifications, particularly glycosylation, can significantly impact antibody recognition of SPBC16C6.04 and similar cell wall proteins. Based on studies of related proteins in S. pombe, both N-glycosylation and O-mannosylation can mask epitopes or create steric hindrance for antibody binding .

Analytical approach to addressing modification challenges:

Research shows that S/T-rich regions in proteins like Sup11p are prone to heavy O-mannosylation, which can mask unusual N-glycosylation sequons (like N-X-A) that might otherwise be recognized by N-glycosylation machinery . When studying SPBC16C6.04, researchers should consider this competition between glycosylation types in experimental design and antibody selection.

What are the best immunoprecipitation protocols for studying SPBC16C6.04 interactions with other cell wall components?

For studying interactions between SPBC16C6.04 and other cell wall components, specialized immunoprecipitation (IP) protocols are necessary:

• Cross-linking IP: Use formaldehyde (1%) or specialized cross-linkers to stabilize transient interactions before cell lysis. This is particularly important for capturing interactions within the complex cell wall matrix .

• Two-step IP protocol:

  • First immunoprecipitate SPBC16C6.04 using specific antibodies

  • Gently elute under native conditions

  • Analyze co-precipitating glucan polymers using specific antibodies against β-1,6-glucan and β-1,3-glucan

• Fractionation-based approach:

  • Separate cell wall fractions containing different glucan polymers

  • Perform IP from each fraction

  • Analyze protein interactions specific to each glucan type

• Conformation-sensitive antibodies: If studying protein-protein interactions within the secretory pathway (ER to Golgi to plasma membrane), use antibodies that recognize conformational epitopes preserved under mild lysis conditions .

• Sequential extraction: Perform sequential extractions with increasingly harsh conditions to distinguish between proteins with different degrees of integration into the cell wall matrix before IP experiments .

How can immunofluorescence microscopy be optimized for visualizing SPBC16C6.04 localization during cell division?

Optimizing immunofluorescence microscopy for SPBC16C6.04 localization during cell division requires several specialized considerations:

• Fixation protocol: For S. pombe, use a modified methanol fixation (-20°C for 6 minutes) followed by partial cell wall digestion with zymolyase to improve antibody accessibility while preserving septum structures .

• Cell cycle synchronization: For capturing specific stages of cell division, particularly septum formation where cell wall proteins play crucial roles, synchronize cells using:

  • Hydroxyurea block and release

  • cdc25-22 temperature-sensitive mutant

  • Lactose gradient centrifugation to isolate cells at specific cell cycle stages

• Co-labeling strategy:

  • Use calcofluor white to visualize septum formation

  • Co-stain with anti-β-1,6-glucan antibodies to correlate SPBC16C6.04 localization with glucan synthesis

  • Include nuclear staining (DAPI) for precise determination of mitotic stage

• Sequential imaging approach: For proteins that change localization during septum formation, use time-lapse immunofluorescence with fixed cells from sequential time points during synchronized division .

• Super-resolution techniques: Employ structured illumination microscopy (SIM) or stochastic optical reconstruction microscopy (STORM) to resolve the precise localization within the ~100nm thick septum structure.

What is the recommended workflow for generating and validating custom antibodies against SPBC16C6.04?

For generating custom antibodies against SPBC16C6.04, a comprehensive workflow should be followed:

• Antigen design and production:

  • Identify unique, accessible epitopes using structure prediction tools

  • Express recombinant protein fragments as immunogens (avoid transmembrane regions)

  • Purify using affinity chromatography methods similar to those used for other yeast proteins

• Immunization and antibody production:

  • Use mouse B cells for monoclonal antibody development through hybridoma technology

  • Consider rabbit hosts for polyclonal antibodies when conformational epitopes are important

• Screening and purification:

  • Screen hybridoma supernatants against recombinant protein

  • Purify IgG fraction using Protein A affinity chromatography

  • Perform additional affinity purification against the specific antigen

• Validation tests:

  • Western blotting comparing wild-type and mutant strains

  • Immunoprecipitation efficiency analysis

  • Immunofluorescence microscopy to confirm expected localization patterns

  • Peptide competition assays to confirm specificity

• Cross-reactivity assessment:

  • Test against related S. pombe proteins with sequence similarity

  • Validate in strains with varying expression levels of the target protein

Why might antibodies against SPBC16C6.04 show inconsistent results in different experimental conditions?

Inconsistent results with SPBC16C6.04 antibodies can stem from several variables that affect protein conformation, accessibility, and antibody binding:

• Glycosylation heterogeneity: Cell wall proteins in S. pombe exhibit variable glycosylation patterns depending on growth conditions and genetic background. Studies on related proteins show that O-mannosylation can mask epitopes in S/T-rich regions . Test antibody recognition after enzymatic deglycosylation to determine if glycosylation is affecting epitope accessibility.

• Growth phase variations: Expression and localization of cell wall proteins change dramatically between logarithmic and stationary phases. Standardize cell collection protocols to harvest cells at consistent OD600 values .

• Strain-specific differences: Different laboratory strains may have subtle variations in cell wall composition. Always include a reference strain as control in each experiment .

• Buffer composition effects: The presence of detergents, reducing agents, and salts can significantly alter protein conformation and antibody binding:

• Fixation artifacts: For microscopy applications, different fixation methods can dramatically affect epitope preservation. Compare methanol, paraformaldehyde, and glutaraldehyde fixation to determine optimal conditions .

How can I distinguish between specific and non-specific binding when using antibodies against S. pombe cell wall proteins?

Distinguishing specific from non-specific binding requires multiple control experiments:

• Genetic validation: The gold standard control is comparing antibody reactivity in wild-type versus deletion/depletion mutants of SPBC16C6.04 (if viable). For essential genes, use conditional repression systems like the nmt81-promoter described for sup11+ .

• Peptide competition assay: Pre-incubate the antibody with excess peptide antigen to block specific binding sites. Specific signals should be eliminated while non-specific binding will persist .

• Secondary antibody-only controls: Perform parallel experiments omitting the primary antibody to identify background from secondary antibody binding.

• Cross-species reactivity: Test the antibody against comparable samples from related yeast species lacking close homologs of SPBC16C6.04 to identify cross-reactivity.

• Signal persistence after protein degradation: Treat samples with general protease digestion - specific signals should diminish while non-specific interaction with carbohydrates or lipids may persist.

• Immunoprecipitation validation: Verify that immunoprecipitated proteins match expected molecular weight and identity by mass spectrometry analysis .

What approaches can overcome the challenges of working with antibodies against low-abundance membrane proteins in S. pombe?

Detecting low-abundance membrane proteins like SPBC16C6.04 requires specialized approaches:

• Sample enrichment strategies:

  • Subcellular fractionation to isolate membrane-enriched fractions

  • Leverage tagged versions with established enrichment methods

  • Use detergent-based differential extractions to concentrate membrane proteins

• Signal amplification methods:

  • Use high-sensitivity chemiluminescent substrates for Western blotting

  • Apply tyramide signal amplification (TSA) for immunofluorescence

  • Consider proximity ligation assay (PLA) for detecting protein interactions with enhanced sensitivity

• Expression optimization:

  • Use the nmt1 promoter system in defined conditions to temporarily increase target protein expression

  • Time sampling to catch peak expression windows during the cell cycle

• Advanced detection platforms:

  • Switch from conventional Western blotting to capillary electrophoresis immunoassay systems

  • Employ single-molecule detection techniques for ultralow abundance proteins

• Specialized antibody approaches:

  • Use cocktails of multiple antibodies targeting different epitopes of the same protein

  • Consider recombinant antibody fragments with improved penetration into complex structures

How should I analyze antibody data when studying the effects of protein glycosylation mutations on SPBC16C6.04?

When studying glycosylation effects on SPBC16C6.04, careful data analysis is essential:

• Migration pattern analysis: S. pombe cell wall proteins typically show diffuse migration patterns on SDS-PAGE due to heterogeneous glycosylation. Analyze mobility shifts systematically:

• Quantitative Western blot analysis: Use dilution series of samples to ensure signals fall within the linear detection range. Normalize to consistent loading controls appropriate for the subcellular fraction being analyzed .

• Glycosylation site mapping: Correlate observed molecular weight shifts with predicted glycosylation sites. S/T-rich regions are typically O-mannosylated, while N-X-S/T sequons (or sometimes N-X-A in specific contexts) indicate potential N-glycosylation .

• Competition analysis: In glycosylation mutants, analyze whether alterations in one type of glycosylation affect other modifications. Research shows that O-mannosylation can sometimes compete with N-glycosylation at nearby sites .

• Functional correlation: Determine whether glycosylation changes correlate with alterations in protein function, stability, or localization by combining Western blot data with functional assays and microscopy .

What statistical approaches are most appropriate for analyzing quantitative immunoblot data for SPBC16C6.04?

For robust quantitative analysis of immunoblot data:

• Experimental design considerations:

  • Plan for minimum three biological replicates

  • Include technical replicates within each biological sample

  • Incorporate randomization of sample loading order to avoid edge effects

  • Use consistent exposure times across compared blots

• Normalization strategies:

  • Normalize to total protein using stain-free technology rather than single housekeeping proteins

  • For membrane proteins, use stable membrane markers appropriate to the specific compartment

  • Consider normalizing to cell number/OD600 when comparing samples with potentially different protein content

• Statistical analysis framework:

  • Use ANOVA with post-hoc tests for multi-condition comparisons

  • Apply non-parametric tests (Mann-Whitney U or Kruskal-Wallis) when normality cannot be assumed

  • Use paired analyses when comparing treatments within the same biological samples

• Handling variability:

  • Report coefficient of variation (%CV) for replicate measurements

  • Establish acceptance criteria for technical replicate variability (typically <15% CV)

  • Use confidence intervals rather than p-values alone for more informative reporting

• Advanced analytical approaches:

  • Consider Bayesian statistical frameworks for small sample sizes

  • Use ANCOVA when controlling for covariates like growth rate

  • Apply mixed-effects models when handling nested data structures (e.g., experiments performed across different days)

How can transcriptome data complement antibody-based studies of SPBC16C6.04 function?

Integrating transcriptome data with antibody-based studies provides powerful insights:

• Expression correlation analysis: Compare SPBC16C6.04 protein levels (from quantitative immunoblotting) with mRNA expression across conditions to identify post-transcriptional regulation mechanisms. Studies on related proteins show that transcriptome analysis can reveal coordinated regulation of cell wall components .

• Regulatory network reconstruction:

  • Use transcriptome data from mutants with altered SPBC16C6.04 expression to identify downstream genes

  • Analyze upstream regulators by comparing transcriptome data across perturbations

  • Build network models integrating protein-level and transcript-level changes

• Functional grouping of co-regulated genes:

  • Identify genes whose expression correlates with SPBC16C6.04 across conditions

  • Perform GO term enrichment and pathway analysis on co-regulated gene sets

  • Connect to phenotypic data to validate predictions

• Mutant characterization enhancement:

  • Analyze transcriptome data from SPBC16C6.04 mutants to identify compensatory responses

  • The third search result shows that in a triple-oma mutant, 439 genes were up-regulated and 239 down-regulated, revealing widespread cellular responses to cell wall perturbations

• Temporal dynamics integration:

  • Combine time-course protein localization data from antibody studies with transcriptome dynamics

  • Identify time-delayed correlations between transcript changes and protein localization/function

  • Track cell cycle-specific regulation patterns

How can I apply antibody-based techniques to study SPBC16C6.04 involvement in septum formation?

To investigate SPBC16C6.04's role in septum formation:

• High-resolution time-lapse imaging:

  • Use synchronized cultures to capture cells at different stages of septation

  • Apply fluorescently-labeled antibodies in fixed cells at sequential time points

  • Combine with calcofluor white staining to visualize the septum structure

• Co-localization with septum markers:

  • Perform dual immunofluorescence with antibodies against SPBC16C6.04 and known septum components

  • Use structured illumination microscopy to resolve the three layers of the septum (primary septum and secondary septa)

  • Quantify co-localization using appropriate statistical measures (Pearson's coefficient, Manders' overlap)

• Immuno-electron microscopy:

  • Apply gold-labeled antibodies to ultrathin sections of dividing cells

  • Precisely localize SPBC16C6.04 relative to the electron-dense primary septum and secondary septa

  • Correlate with β-1,6-glucan immunogold labeling patterns

• Conditional mutant analysis:

  • Use the nmt81-promoter system to create conditional knockdowns similar to those used for sup11+

  • Apply antibodies to track protein depletion timing relative to septum defect appearance

  • Document morphological changes using electron microscopy as used in studies of related proteins

• Live-cell antibody fragment imaging:

  • Use fluorescently labeled Fab fragments in semi-permeabilized cells

  • Track protein dynamics during septum closure and separation

  • Correlate with known septum formation timing (16-30 minutes in the S. pombe cell cycle)

What are the most sensitive approaches for detecting SPBC16C6.04 interactions with cell wall glucan structures?

For detecting interactions between SPBC16C6.04 and glucan structures:

• Proximity labeling techniques:

  • Express SPBC16C6.04 fused to a proximity labeling enzyme (BioID or APEX2)

  • Identify proximal glucan-modifying enzymes and structural components

  • Validate interactions using co-immunoprecipitation with specific antibodies

• In situ cross-linking mass spectrometry:

  • Apply cell-permeable cross-linkers to intact cells

  • Immunoprecipitate SPBC16C6.04 using specific antibodies

  • Analyze cross-linked peptides by mass spectrometry to identify direct interaction partners

• Fluorescence resonance energy transfer (FRET):

  • Use antibodies labeled with compatible FRET pairs

  • Target SPBC16C6.04 and glucan structures or glucan synthases

  • Measure FRET signals to identify molecular proximity (<10nm)

• Split-reporter reconstitution assays:

  • Fuse SPBC16C6.04 and potential interaction partners to complementary fragments of a reporter protein

  • Detect interactions through reconstituted reporter activity

  • Validate with antibody-based co-localization studies

• Glycan microarray analysis:

  • Prepare arrays of purified cell wall components (β-1,3-glucan, β-1,6-glucan, α-galactomannan)

  • Apply purified SPBC16C6.04 protein

  • Detect binding using specific antibodies against SPBC16C6.04

  • Determine binding specificity and affinity for different glucan structures

What are the key considerations for selecting the most appropriate antibody-based techniques for specific SPBC16C6.04 research questions?

Selecting appropriate antibody techniques for SPBC16C6.04 research requires careful consideration of:

• Research question specificity: Match techniques to specific aspects of protein function:

  • Localization studies: Immunofluorescence or immunoelectron microscopy

  • Protein-protein interactions: Co-immunoprecipitation or proximity labeling

  • Post-translational modifications: Specific modification-sensitive antibodies

  • Functional studies: Antibody inhibition or conditional depletion with antibody tracking

• Technical limitations assessment:

  • Epitope accessibility in fixed versus live cells

  • Antibody specificity and validation status

  • Required sensitivity relative to protein abundance

  • Compatibility with sample preparation methods

• Complementary methodology integration:

  • Combine antibody approaches with genetic methods

  • Integrate with functional assays of cell wall integrity

  • Correlate with transcriptomic and proteomic datasets

• Controls and validation hierarchy:

  • Prioritize genetic controls (deletion/depletion strains)

  • Include peptide competition controls

  • Apply orthogonal detection methods for key findings

• Emerging technology consideration:

  • Evaluate super-resolution microscopy applications for detailed localization

  • Consider single-molecule tracking for dynamic studies

  • Explore multiplexed antibody approaches for system-level analysis

By carefully matching techniques to specific research questions and ensuring proper controls, researchers can maximize the value of antibody-based approaches in understanding SPBC16C6.04's role in S. pombe cell wall biology and septum formation.

How might future antibody technologies enhance our understanding of SPBC16C6.04 function in cell wall dynamics?

Emerging antibody technologies promise to revolutionize our understanding of proteins like SPBC16C6.04:

• Nanobody and single-domain antibody applications:

  • Smaller size allows better penetration into dense cell wall structures

  • Potential for live-cell imaging with minimal functional interference

  • Higher stability under various buffer conditions for multiple applications

• Multiplexed imaging technologies:

  • Simultaneous visualization of multiple cell wall components

  • Spatial proteomics applications to map protein neighborhoods

  • Integration with machine learning for pattern recognition in complex localizations

• Spatially-resolved antibody-based proteomics:

  • Antibody-based capture of protein complexes with spatial preservation

  • Region-specific analysis of cell wall composition at division sites

  • Correlation with functional domains within the cell

• Conformation-specific antibodies:

  • Detection of active versus inactive protein states

  • Monitoring of dynamic conformational changes during cell cycle progression

  • Identification of interaction-induced structural alterations

• Integrative multi-scale approaches:

  • Combining molecular-level antibody data with cell-scale phenotypic measurements

  • Bridging temporal scales from rapid protein dynamics to cell cycle progression

  • Creating predictive models of cell wall assembly and remodeling during growth and division